Related Experiment Video
Updated: Jul 29, 2026

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile
1Department of Infectious Diseases and Tropical Medicine, San Bortolo Hospital, Vincenza, Italy.
Objectives:
The aims of this study were to evaluate the prevalence and impact of Chlamydia pneumoniae infection in HIV-positive patients and to establish the relationship between C. pneumoniae infection and lipid profile.
Methods:
Detection of C. pneumoniae was by polymerase chain reaction (PCR) on Peripheral Blood Mononuclear Cells (PBMCs) collected from 97 HIV-positive patients. Samples were collected after overnight fast in EDTA-treated tubes. On the same day, patients were also tested for routine chemistry, HIV viral load, CD3, CD8 and CD4 cell counts and lipid profile [cholesterol, high-density lipoproteins (HDLs), low-density lipoproteins (LDLs) and triglycerides].
Results:
The overall prevalence of C. pneumoniae was 39%. The prevalence of C. pneumoniae was inversely related to the CD4 lymphocyte count (P=0.03). In the naive group, C. pneumoniae-positive patients had both significantly higher HIV load (71 021+/-15 327 vs. 14 753+/-14 924 HIV-1 RNA copies/mL; P=0.03) and lower CD4 cell count (348.0+/-165.4 vs. 541.7+/-294.8; P=0.04) than C. pneumoniae-negative patients. Moreover, treatment-naive patients with C. pneumoniae infection had significantly higher mean levels of cholesterol (185.3+/-56.2 vs. 124.8+/-45.9 mg/dL; P=0.01), triglycerides (117.2+/-74.7 vs. 68+/-27.6 mg/dL; P=0.04) and LDL (122.4+/-60.1 vs. 55.6+/-58 mg/dL; P=0.05) than C. pneumoniae-negative patients.
Conclusions:
These data indicate that, in HIV-positive subjects, C. pneumoniae infection is relatively frequent and is associated with both low CD4 cell count and high HIV load. Furthermore, C. pneumoniae appears to be associated with hyperlipidaemia and might therefore represent a further risk factor for cardiovascolar disease in HIV-positive patients.
Insights
Chlamydia pneumoniae infection is common in HIV-positive individuals, linked to lower CD4 counts and higher HIV viral load. This infection may also increase cardiovascular disease risk due to associated hyperlipidemia.
Area of Science:
- Infectious Diseases
- Immunology
- Cardiovascular Health
Background:
- HIV infection significantly impacts immune function and cardiovascular health.
- Chlamydia pneumoniae is an opportunistic pathogen with potential implications in immunocompromised individuals.
- Understanding coinfections in HIV patients is crucial for managing comorbidities.
Purpose of the Study:
- To determine the prevalence of Chlamydia pneumoniae infection in HIV-positive patients.
- To assess the impact of C. pneumoniae infection on CD4 cell counts and HIV viral load.
- To investigate the association between C. pneumoniae infection and lipid profiles in this population.
Main Methods:
- Polymerase chain reaction (PCR) was used to detect C. pneumoniae in Peripheral Blood Mononuclear Cells (PBMCs) from 97 HIV-positive patients.
- Collected samples were analyzed for C. pneumoniae, HIV viral load, CD4/CD8 cell counts, and lipid profiles (cholesterol, HDL, LDL, triglycerides).
- Patient data included CD4 lymphocyte counts and HIV viral load.
Main Results:
- The prevalence of C. pneumoniae infection was 39% among the studied HIV-positive patients.
- C. pneumoniae infection was inversely correlated with CD4 lymphocyte count (P=0.03).
- In treatment-naive patients, C. pneumoniae positivity was associated with higher HIV viral load, lower CD4 counts, and significantly elevated cholesterol, triglyceride, and LDL levels.
Conclusions:
- C. pneumoniae infection is prevalent in HIV-positive individuals and associated with poorer immunological status (low CD4 count) and higher viral load.
- The findings suggest a link between C. pneumoniae infection and hyperlipidemia in HIV patients.
- C. pneumoniae may represent an additional risk factor for cardiovascular disease in the context of HIV infection.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
09:54Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Atypical Pneumonia
Cryptococcal Meningitis
Pneumonia I: Introduction